Latest Insider Transactions at Enfusion, Inc. (ENFN)
This section provides a real-time view of insider transactions for Enfusion, Inc. (ENFN). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Enfusion, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Enfusion, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Aug 12
2022
|
Oleg Movchan Chief Executive Officer |
SELL
Other acquisition or disposition
|
Indirect |
400,000
-28.53%
|
-
|
|
Jun 15
2022
|
Jan Hauser Director |
BUY
Grant, award, or other acquisition
|
Direct |
12,678
+30.26%
|
-
|
|
Jun 15
2022
|
Kathleen De Rose Director |
BUY
Grant, award, or other acquisition
|
Direct |
12,678
+30.26%
|
-
|
|
Jun 15
2022
|
Lawrence E Leibowitz Director |
BUY
Grant, award, or other acquisition
|
Direct |
12,678
+20.11%
|
-
|
|
Jun 15
2022
|
Bronwen Bastone Chief People Officer |
BUY
Grant, award, or other acquisition
|
Direct |
86,339
+35.49%
|
-
|
|
Jun 15
2022
|
Stephen M Dorton Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
10,142
+5.15%
|
-
|
|
Jun 15
2022
|
Dan Groman Chief Technology Officer |
BUY
Grant, award, or other acquisition
|
Direct |
6,339
+5.57%
|
-
|
|
Jun 15
2022
|
Lorelei M. Skillman Chief Mrktg. & Comm. Officer |
BUY
Grant, award, or other acquisition
|
Direct |
5,071
+10.17%
|
-
|
|
Jun 15
2022
|
Thomas Kim Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
20,284
+2.29%
|
-
|
|
May 11
2022
|
Oleg Movchan Chief Executive Officer |
BUY
Conversion of derivative security
|
Indirect |
1,401,818
+50.0%
|
-
|
|
Oct 31
2021
|
Jan Hauser Director |
BUY
Grant, award, or other acquisition
|
Direct |
16,544
+37.5%
|
-
|
|
Oct 31
2021
|
Kathleen De Rose Director |
BUY
Grant, award, or other acquisition
|
Direct |
16,544
+37.5%
|
-
|
|
Oct 31
2021
|
Lawrence E Leibowitz Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,515
+12.77%
|
-
|
|
Oct 25
2021
|
Bradford E Bernstein Director |
SELL
Open market or private sale
|
Indirect |
4,075,531
-11.52%
|
$61,132,965
$15.89 P/Share
|
|
Oct 25
2021
|
Hillhouse Investment Management, Ltd. > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
647,862
-11.52%
|
$9,717,930
$15.89 P/Share
|
|
Oct 25
2021
|
Iconiq Strategic Partners V, L.P. > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
722,707
+50.0%
|
$12,286,019
$17.0 P/Share
|
|
Oct 25
2021
|
Iconiq Strategic Partners V, L.P. > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
538,887
+50.0%
|
$9,161,079
$17.0 P/Share
|
|
Oct 25
2021
|
Roy Luo Director |
BUY
Open market or private purchase
|
Indirect |
1,261,594
+50.0%
|
$21,447,098
$17.0 P/Share
|